Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 48% ± 18% | |
oligodendrocyte precursor cell | 12 studies | 59% ± 20% | |
GABAergic neuron | 9 studies | 56% ± 18% | |
oligodendrocyte | 7 studies | 33% ± 20% | |
interneuron | 6 studies | 51% ± 21% | |
astrocyte | 6 studies | 34% ± 26% | |
neuron | 5 studies | 36% ± 15% | |
endothelial cell | 5 studies | 31% ± 13% | |
granule cell | 4 studies | 41% ± 17% | |
microglial cell | 4 studies | 34% ± 26% | |
retinal ganglion cell | 4 studies | 60% ± 24% | |
GABAergic interneuron | 3 studies | 59% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 13 studies | 36% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 92% | 25.80 | 2437 / 2642 | 16% | 0.29 | 115 / 705 |
ovary | 98% | 52.38 | 176 / 180 | 1% | 0.08 | 3 / 430 |
bladder | 67% | 22.76 | 14 / 21 | 1% | 0.09 | 7 / 504 |
breast | 65% | 15.05 | 298 / 459 | 0% | 0.01 | 4 / 1118 |
intestine | 46% | 6.79 | 442 / 966 | 0% | 0.02 | 2 / 527 |
skin | 45% | 8.35 | 816 / 1809 | 1% | 0.03 | 3 / 472 |
adipose | 44% | 12.91 | 526 / 1204 | 0% | 0 | 0 / 0 |
prostate | 39% | 6.78 | 96 / 245 | 0% | 0.03 | 2 / 502 |
stomach | 25% | 3.19 | 89 / 359 | 0% | 0.02 | 1 / 286 |
uterus | 23% | 2.68 | 39 / 170 | 2% | 0.15 | 9 / 459 |
pancreas | 17% | 1.62 | 57 / 328 | 1% | 0.03 | 2 / 178 |
liver | 11% | 0.89 | 25 / 226 | 3% | 0.09 | 13 / 406 |
kidney | 11% | 1.30 | 10 / 89 | 0% | 0.01 | 4 / 901 |
spleen | 12% | 1.04 | 28 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 7% | 0.57 | 19 / 258 | 2% | 0.10 | 4 / 230 |
thymus | 1% | 0.11 | 9 / 653 | 5% | 0.25 | 29 / 605 |
esophagus | 2% | 0.16 | 30 / 1445 | 2% | 0.07 | 4 / 183 |
muscle | 3% | 0.26 | 26 / 803 | 0% | 0 | 0 / 0 |
lung | 0% | 0.01 | 1 / 578 | 2% | 0.05 | 28 / 1155 |
blood vessel | 2% | 0.36 | 33 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
peripheral blood | 1% | 0.08 | 10 / 929 | 0% | 0 | 0 / 0 |
heart | 0% | 0.01 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048738 | Biological process | cardiac muscle tissue development |
GO_0061024 | Biological process | membrane organization |
GO_0060047 | Biological process | heart contraction |
GO_0046716 | Biological process | muscle cell cellular homeostasis |
GO_0055001 | Biological process | muscle cell development |
GO_0016012 | Cellular component | sarcoglycan complex |
GO_0042383 | Cellular component | sarcolemma |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
Gene name | SGCZ |
Protein name | SGCZ protein (Sarcoglycan zeta) Zeta-sarcoglycan (Zeta-SG) (ZSG1) |
Synonyms | |
Description | FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. May play a role in the maintenance of striated muscle membrane stability (By similarity). . |
Accessions | Q96LD1 Q08AT0 ENST00000421524.6 ENST00000382080.6 [Q96LD1-2] |